| PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer Frontiers in pharmacology 8, 561, 2017 | 1642 | 2017 |
| siRNA delivery strategies: a comprehensive review of recent developments K Tatiparti, S Sau, SK Kashaw, AK Iyer Nanomaterials 7 (4), 77, 2017 | 467 | 2017 |
| Advances in antibody–drug conjugates: A new era of targeted cancer therapy S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer Drug Discovery Today 22 (10), 1547-1556, 2017 | 164 | 2017 |
| Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers KA Gawde, S Sau, K Tatiparti, SK Kashaw, M Mehrmohammadi, AS Azmi, ... Colloids and Surfaces B: Biointerfaces 167, 8-19, 2018 | 89 | 2018 |
| Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors S Reddy, K Tatiparti, S Sau, AK Iyer Drug Discovery Today 26 (8), 1944-1952, 2021 | 76 | 2021 |
| PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017; 8: 561 HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer Frontiers Media SA DOI 10, 2017 | 70 | 2017 |
| Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance K Vanamala, K Tatiparti, K Bhise, S Sau, MH Scheetz, MJ Rybak, D Andes, ... Drug discovery today 26 (1), 31-43, 2021 | 53 | 2021 |
| Transferrin: biology and use in receptor-targeted nanotherapy of gliomas T Koneru, E McCord, S Pawar, K Tatiparti, S Sau, AK Iyer ACS omega 6 (13), 8727-8733, 2021 | 46 | 2021 |
| Folate receptors’ expression in gliomas may possess potential nanoparticle-based drug delivery opportunities E McCord, S Pawar, T Koneru, K Tatiparti, S Sau, AK Iyer ACS omega 6 (6), 4111-4118, 2021 | 38 | 2021 |
| Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor … K Tatiparti, S Sau, KA Gawde, AK Iyer International Journal of Molecular Sciences 19 (3), 838, 2018 | 30 | 2018 |
| A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy S Sau, K Tatiparti, HO Alsaab, SK Kashaw, AK Iyer Drug Discovery Today 23 (7), 1344-1356, 2018 | 29 | 2018 |
| LDL receptors and their role in targeted therapy for glioma: a review S Pawar, T Koneru, E McCord, K Tatiparti, S Sau, AK Iyer Drug Discovery Today 26 (5), 1212-1225, 2021 | 28 | 2021 |
| Review on self micro emulsifying drug delivery systems S Reddy, T Katyayani, A Navatha, G Ramya Int J Res Pharm Sci 2 (3), 382-92, 2011 | 27 | 2011 |
| Carbonic anhydrase-IX guided albumin nanoparticles for hypoxia-mediated triple-negative breast cancer cell killing and imaging of patient-derived tumor K Tatiparti, MA Rauf, S Sau, AK Iyer Molecules 25 (10), 2362, 2020 | 18 | 2020 |
| Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease K Tatiparti, S Sau, MA Rauf, AK Iyer Drug Discovery Today 25 (12), 2110-2129, 2020 | 15 | 2020 |
| Nano‐therapeutic strategies to target coronavirus MA Rauf, M Tasleem, K Bhise, K Tatiparti, S Sau, AK Iyer View 2 (3), 20200155, 2021 | 12 | 2021 |
| Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes R Alzhrani, HO Alsaab, K Vanamala, K Bhise, K Tatiparti, A Barari, S Sau, ... Advanced Therapeutics, 2000262, 2021 | 11 | 2021 |
| LIPOSOMES – THE FUTURE OF FORMULATIONS M Sivasankar, K Tatiparti INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY 1 (2), 259-267, 2011 | 9 | 2011 |
| A Biomimetic drug delivery system targeting tumor hypoxia in triple-negative breast cancers K Tatiparti, MA Rauf, S Sau, AK Iyer Applied Sciences 10 (3), 1075, 2020 | 4 | 2020 |
| Nanomedicine for overcoming therapeutic and diagnostic challenges associated with pancreatic cancer D Iyengar, K Tatiparti, NS Gavande, S Sau, AK Iyer Drug Discovery Today 27 (6), 1554-1559, 2022 | 3 | 2022 |
Arun Iyer, PhD, Associate Professor of...Wayne State University, Karmanos Cancer Institute, UCSF, Northeastern UniversityVerified email at wayne.edu
